Latest news with #TowardsHealthcare
Yahoo
05-05-2025
- Business
- Yahoo
Cancer Diagnostics Market Size Drives to USD 199.54 Billion by 2034
According to Towards Healthcare Research, the global cancer diagnostics market size is calculated at USD 116.42 billion in 2025 and is expected to reach around USD 199.54 billion by 2034, growing at a CAGR of 6.17% for the forecasted period. Ottawa, May 05, 2025 (GLOBE NEWSWIRE) -- The global cancer diagnostics market size was valued at USD 109.65 billion in 2024 and is predicted to hit around USD 199.54 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The rising prevalence of cancer and advancements in diagnostics are the major growth factors of the market. North America led the global market owing to the increasing awareness of early diagnosis and robust healthcare infrastructure. Get All the Details in Our Solutions – Request a Brochure: Cancer Diagnostics Market Overview Cancer diagnostics are tools used to detect the presence of tumors. The most commonly used tests for diagnosing cancer include CT scan, MRI, PET scan, ultrasound, and X-ray. Other types of tests include lab tests and biopsies. Lab tests identify the cancer biomarkers, whereas biopsy and imaging tests confirm the presence of tumors. These tests enable healthcare professionals to determine the extent of cancer (stage) and provide treatment accordingly. Effective diagnostic testing confirms or eliminates the presence of disease, monitors the disease process, and plans for and evaluates the effectiveness of treatment. Cancer Diagnostics Market Trends Rising Prevalence of Cancer: The rising prevalence of cancer is a major public health concern as it is the leading cause of mortality globally. The World Health Organization (WHO) reported 20 million new cancer cases in 2022 globally and estimated over 35 million new cases in 2050 globally. Advancements in Diagnostics: Researchers around the globe develop advanced techniques and tools for early cancer detection. Advanced technologies are used for diagnosing cancer. Some common examples of advanced diagnostics include liquid biopsy and AI-driven imaging. Growing Genomics & Proteomics Research: Genomics and proteomics play a vital role in determining the type and amount of biomarkers present in the human body. They provide insights into molecular mechanisms and potential therapeutic targets for personalized medicines. Limitations & Challenges of the Cancer Diagnostics Market Lack of Awareness: Numerous people in developing and underdeveloped countries are unaware of cancer screening and early diagnosis. This hinders the use of cancer diagnostics, leading to cancer detection at later stages. High Cost: Several advanced diagnostic techniques are not affordable to people, especially from low- and middle-income groups. This may lead to unequal access to advanced technologies for a wide range of people. You can place an order or ask any questions, please feel free to contact us at sales@ AI-driven Cancer Diagnostics: Revolutionizing Detection AI in cancer diagnostics is one of the most widely adopted techniques due to enhanced accuracy and efficiency. Integrating AI in MRI, CT scans, PET, and other imaging tests analyzes mammograms and biopsy images. AI can detect minute signs that are not visible to healthcare professionals, aiding them in detecting cancerous lesions and understanding tumor behavior. It enhances the speed of cancer diagnosis, enabling providers to focus more on patient care. AI and ML can detect vast amounts of data and precisely detect the cancer stage. This helps healthcare professionals to provide personalized treatment based on imaging results. Thus, AI has been studied to detect and screen different cancer types, affecting the breast, lungs, brain, pancreas, rectum, and oesophagus. AI In Cancer Diagnostics Market Report: Regional Analysis Increasing Investments Dominated North America North America dominated the global cancer diagnostics market in 2024. The presence of a robust healthcare infrastructure and technological advancements leads to the use of cutting-edge diagnostic solutions. State-of-the-art research and development facilities encourage researchers to identify potential biomarkers and develop tools for faster and more precise detection. Favorable reimbursement policies enable patients to access advanced care, contributing to market growth. The growing demand for personalized treatment helps doctors to use cutting-edge diagnostic techniques. United States: The American Cancer Society estimated more than 2 million new cancer cases in the U.S. in 2025. The increasing number of cancer-related clinics also potentiates market growth. There are around 72 NCI-designated cancer centers in the U.S. The National Cancer Institute invests around $7.2 billion annually in cancer research. Canada: In March 2025, the Government of Alberta announced an investment of CAD 800 million (USD 560 million) over eight years as part of the partnership with Siemens Healthineers and the Alberta Cancer Foundation. The funding was made to support early cancer detection, reduce wait times, and establish Alberta as a leader in cancer research and innovation. Asia-Pacific is anticipated to grow at the fastest rate in the cancer diagnostics market during the forecast period. The rising prevalence of cancer and the increasing adoption of advanced technologies drive the market. Several government and private organizations conduct seminars and workshops to create awareness about screening and cancer detection, thereby improving access to healthcare services. The increasing investments and collaborations also promote the market. The burgeoning healthcare sector and increasing healthcare expenditure boost market growth. Asia-Pacific countries provide affordable cancer diagnosis and treatment services, encouraging people from around the globe to access medical services in these countries. China: In November 2024, the Advanced Prostate Cancer Consensus Conference (APCCC) was organized in China to address the rising incidence of prostate cancer. The conference discussed public awareness campaigns and localized screening programs, highlighting China's progress. India: The Indian Council of Medical Research (ICMR) reported more than 14 lakh new cancer cases in India in 2023. The Indian government aims for an integrated approach for a 'Cancer-free India,' encompassing prevention, screening, diagnosis, and treatment. The Union Budget 2025-26 prioritizes cancer care by allocating a budget of Rs. 99,858.56 crore. Get the latest insights on healthcare industry segmentation with our Annual Membership: Segmental Outlook Product Insights The consumables segment held a dominant presence in the cancer diagnostics market in 2024. Consumables are common materials required for molecular diagnostics, including fixatives, stains, antibodies, probes, kits, and specialized reagents. They are refilled at diagnostic laboratories and other healthcare organizations to perform multiple tests simultaneously. They play a vital role in routine testing and the frequent use of cancer diagnostics. The availability of affordable consumables encourages professionals to purchase them. The services segment is predicted to witness significant growth in the market over the forecast period. Several organizations provide proficient expertise and access to cutting-edge technologies, which are otherwise unaffordable to laboratories. Services eliminate the need for favorable infrastructure and skilled professionals. They provide additional testing for patients with symptoms, imaging, or lab results that require new diagnostic techniques. They reduce the chance of false positives, giving accurate results. Type Insights The in vitro diagnostics (IVDs) segment led the global cancer diagnostics market in 2024. IVDs aid in the screening and diagnosis of various cancer types. These tests include liquid biopsies, multi-cancer early detection tests (MCED), and biomarker testing. The growing demand for point-of-care diagnostics augments the segment's growth. They eliminate the need for visiting a pathology lab. Advancements in technology and immunohistochemistry boost the segment's growth. Companion diagnostics are another common example of IVDs that provide information about the safe and effective use of therapeutics. The U.S. Food and Drug Administration (FDA) approved a total of 188 companion diagnostics as of March 2025. The laboratory diagnostic tests segment is expected to grow at the fastest rate in the cancer diagnostics market during the forecast period. Laboratory diagnostic tests (LDTs) are tests that assess a sample of blood, urine, or body tissues to detect tumors. LDTs analyze the amount of biomarkers responsible for cancer progression. Any abnormalities in the normal values of tests enable providers to make effective clinical decisions and might even suggest further advanced diagnostic tests. They are comparatively more affordable than IVDs. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule a call today: Application Insights The breast cancer segment held the largest share of the market in 2024. Breast cancer is the most common type of cancer in women and leads to the highest number of mortalities. In the U.S., breast cancer accounts for 30% of all new cancer cases annually. Mammogram tests are the most widely used diagnostic tool for breast cancer. Digital breast tomosynthesis or 3D mammography is an advanced technique of mammogram tests for detecting hidden tumors and getting clearer images of breast abnormalities. The future of breast cancer screening involves the use of magnets, sound waves, and cellular biology. The colorectal cancer segment is anticipated to grow with the highest CAGR in the cancer diagnostics market during the studied years. The rising prevalence of colorectal cancer fosters the segment's growth. The American Cancer Society estimated about 107,320 new colon cancer cases and 46,950 new rectal cancer cases in 2025. Colorectal cancers are usually diagnosed through stool tests, colonoscopy, and blood-based tests. They are highly treatable. Hence, screening of precancerous polyps is essential. End-Use Insights The laboratories segment held the major share of the market in 2024. Laboratories have skilled professionals to provide advanced diagnostic services to patients. The presence of favorable infrastructure and suitable capital investments enables laboratories to adopt cutting-edge diagnostic techniques for cancer diagnosis. They perform various tests, such as tissue analysis, urinalysis, and tumor markers. Laboratories not only conduct cancer-related tests for patients but also help researchers in identifying potential biomarkers, allowing them to draw conclusions. Test Type Insights The biopsy segment held a significant share of the market in 2024. Biopsy is a procedure to extract tissues, cells, or fluids from local tumor areas and analyze them under a microscope to check for the presence of tumors. They are more accurate and eliminate the chances of false positives. The growing demand for minimally invasive tests propels the segment's growth. The advent of liquid biopsy tests has revolutionized cancer testing. Liquid biopsies identify circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). Coverage Insights The public insurance segment registered its dominance over the global cancer diagnostics market in 2024. Several government bodies provide reimbursement for cancer screening, diagnosis, and treatment through special schemes. Public insurances are generally more affordable and accessible, making them a sustainable option. The increased trust in government insurance policies also encourages patients to prefer public insurance. The Centers for Medicare and Medicaid Services (CMS) provide reimbursement for cancer diagnosis in the U.S. The CMS provides $110 per beneficiary per month for their cancer treatment. The private insurance segment is anticipated to show lucrative growth in the market over the study period. Private insurance policies offer numerous benefits over public insurance, such as less waiting time, selecting doctors of own choice, and access to more healthcare options. Private insurance also helps to save on tax and avoid full-cost private hospital bills. Numerous companies provide personalized policies and schemes, benefiting patients and healthcare professionals. Top Companies in the Cancer Diagnostics Market Illumina, Inc. Becton, Dickinson, and Company GE Healthcare QIAGEN N.V. Abbott Laboratories, Inc. Roche Diagnostics Siemens Healthcare Philips Healthcare R. Bard, Inc. bioMérieux SA NeoGenomics Laboratories, Inc. Volpara Solutions Limited Hologic Inc. Canon Medical Systems Corporation PenRad Technologies Inc. BioNTech Diagnostics GmbH BioGenex Recent Breakthroughs In April 2025, researchers from Karolinska Institute developed a urine test to detect prostate cancer at an early stage. The test enables the use of AI and extensive analyses of gene activity in tumors to identify new biomarkers with high diagnostic accuracy. In November 2024, Alverno Laboratories and Ibex Medical Analytics announced the launch of the Ibex Breast platform within Alverno's laboratories in Indiana and Illinois. The platform uses AI technologies to detect cancer in multiple tissue types, including prostate, breast, and gastric. Browse More Insights of Towards Healthcare: Cervical Cancer Treatment Market Size: Cancer Stem Cells Market Size: Cervical Cancer Diagnostic Market Size: Hyperthermia Cancer Treatment Market Size: Cancer Biologics Market Size: Circulating Tumor Cells Market Size: Cancer Vaccines Market Size: Liver Cancer Drugs Market Size: Hemato Oncology Testing Market: Pancreatic Cancer Market: Segments Covered in the Report By Product Consumables Antibodies Kits & reagents Probes Others Services Instruments Pathology-based Instruments Slide Staining Systems Tissue Processing Systems Cell Processors PCR Instruments NGS Instruments Microarrays Other Pathology-based Instruments Imaging Instruments Others By Type In Vitro Diagnostics By Type Diagnosis Early Detection Therapy Selection Monitoring By Technology Polymerase Chain Reaction (PCR) In Situ Hybridization (ISH) Immunohistochemistry (IHC) Next-generation Sequencing (NGS) Microarrays Flow Cytometry Immunoassays Other IVD Testing Technologies Laboratory Diagnostic Tests Imaging Magnetic Resonance Imaging (MRI) Computed Tomography (CT) Positron Emission Tomography (PET) Mammography Ultrasound Others By Application Breast Cancer Colorectal Cancer Cervical Cancer Lung Cancer Prostate Cancer Skin Cancer Blood Cancer Kidney Cancer Liver Cancer Pancreatic Cancer Ovarian Cancer Others By End-Use Laboratories Hospitals Others By Test Type Biopsy Fine-needle Aspiration Core Biopsy Surgical Biopsy Skin Biopsy /Punch Biopsy Others Others By Coverage Public Insurance Private Insurance By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: in to access your portfolio
Yahoo
02-05-2025
- Health
- Yahoo
Healthcare Staffing Market Size to Expand from USD 45.22 Billion in 2025 to USD 82.92 Billion by 2034
According to Towards Healthcare study, the global healthcare staffing market size is calculated at USD 45.22 billion in 2025 and is expected to reach around USD 82.92 billion by 2034, growing at a CAGR of 6.97% for the forecasted period. Ottawa, May 02, 2025 (GLOBE NEWSWIRE) -- The global healthcare staffing market size was valued at USD 42.27 billion in 2024 and is predicted to hit around USD 82.92 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The growing demand for personalized care and the rising healthcare needs drive the market. North America dominated the global market due to advanced healthcare infrastructure and the presence of skilled professionals. Get All the Details in Our Solutions – Request a Brochure: Market Overview Healthcare staffing is the process of hiring, recruiting, and managing healthcare professionals in any healthcare organization. The staff includes doctors, nurses, allied health professionals, and administrative staff for hospitals, clinics, and nursing homes. Healthcare staffing agencies assess the staffing needs and hire for various purposes, such as short-term assignments, permanent roles, or travel positions. Additionally, staffing agencies consider a region's cultural and linguistic parameters during hiring. These agencies have access to a wide range of professionals, help reduce administrative burden, and provide cost-effective solutions. Healthcare Staffing Market Trends Increasing Number of Hospitalizations: The rising prevalence of several acute and chronic disorders results in an increasing number of hospitalizations. This necessitates advanced patient care and potentiates healthcare needs, requiring trained healthcare professionals. Demand for Personalized Care: Numerous healthcare organizations hire professionals through staffing agencies to reduce administrative burden. This enables them to focus more on patient treatment and provide personalized care. Personalized medicine boosts patients' trust and satisfaction rates. Technological Advancements: The growing adoption of advanced technologies, such as innovative medical devices or telehealth and telemedicine, potentiates the need for skilled healthcare professionals. Staffing agencies assess the eligibility of healthcare professionals and hire them accordingly. You can place an order or ask any questions, please feel free to contact us at sales@ Limitations & Challenges in the Healthcare Staffing Market Lack of Skilled Professionals: Numerous rural or underserved areas have a lack of skilled professionals. This poses a significant challenge for staffing agencies to ensure sufficient qualified professionals are available to provide advanced care. Insufficient Remuneration: Many healthcare professionals believe they are underpaid, especially given the amount of work time. According to a recent survey by Purchasing Power, 53% of healthcare employees reported that they receive inadequate pay for their work. Tech-Driven Hiring Process: Opportunity for the Market Artificial intelligence (AI) in healthcare can revolutionize the healthcare staff hiring process. AI and machine learning (ML) algorithms analyze a vast amount of data and filter a large pool of candidates based on specific requirements. AI and ML enable staffing agencies to understand how well the experience aligns with the job requirements. They aid in scheduling interviews, generate detailed reports on candidates, and save a candidate's profile for future needs. AI-based tools can also notify professionals about job vacancies related to their qualities and allow them to apply accordingly. Moreover, AI and ML reduce biases and accelerate the hiring process. For instance, In January 2025, Hippocratic AI announced that it raised $141 million in a funding round to bolster its AI agent healthcare staffing business. The funding will accelerate the development and deployment of Hippocratic GenAI-driven super staffing in a healthcare organization. Get the latest insights on healthcare industry segmentation with our Annual Membership: Regional Analysis Presence of Skilled Professionals Dominated North America North America dominated the global healthcare staffing market in 2024. The availability of a robust healthcare infrastructure and the growing demand for personalized care boost the market. The increasing number of hospitalizations and the rising prevalence of chronic disorders require skilled professionals for enhanced care. The presence of skilled professionals caters to a large population in North America. United States: There are a total of 933,788 active physicians in the U.S., of which 800,355 provide patient care. There were more than 3.4 million hospital admissions in the U.S. in 2024, necessitating qualified professionals. Canada: In June 2023, the Government of Canada invested $78.5 million in three projects to help train and retain more healthcare workers. This investment marks a significant contribution of the government to support workforce planning, leading to better recruitment & retention and a sustainable ecosystem. Increasing Geriatric Population Promotes Asia-Pacific Asia-Pacific is projected to host the fastest-growing healthcare staffing market in the coming years. The increasing and the rising adoption of advanced technologies potentiate the need for highly qualified healthcare staff. The increasing healthcare expenditure and the burgeoning healthcare sector augment market growth. Several government organizations launch initiatives to tackle healthcare staff shortages owing to the growing population and changing healthcare preferences. China: According to the State Council Information Office, there were more than 14.41 million healthcare workers in China in 2022. It is also estimated that there will be 16 million health workers by 2025. Additionally, healthcare expenditure is expected to reach RMB 205 trillion yuan by 2030. Japan: The Japanese government aims to adopt cutting-edge technologies and strengthen Japan's position in the world. There are around 26 medical doctors per 10,000 population. The geriatric population aged 65 years or older accounts for 29.3% of the total population, amounting to 36.25 million, as of September 2024. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule a call today: Segmental Outlook Service Type Insights The travel nurse staffing segment held a dominant presence in the healthcare staffing market in 2024. Travel nurse refers to a temporary nurse for healthcare organizations requiring urgent staff. The growing staff shortages and the demand for specialized expertise boost the segment's growth. The OUCRU organization estimates that the world faces a shortage of 11 million health workers by 2030. Travel nurses can be hired for several days, weeks, or months, depending on the requirements. They receive higher payments than regular nurses and can pick up casual shifts in different locations. There are approximately 1.7 million traveling nurses in the U.S. The locum tenens staffing segment is expected to grow at the fastest rate in the market during the forecast period. Locum tenens refers to a physician who fills in for another clinician when they are unavailable. By hiring locum tenens, physicians can have complete control over their careers and schedule flexibility while providing advanced patient care. They have numerous advantages, such as reduced administrative burdens, enhanced pay, and opportunities for social and cultural experiences. It is estimated that around 52,000 physicians work temporary locum tenens assignments in the U.S. annually. End-Use Insights The hospitals segment held the largest share of the healthcare staffing market in 2024. The increasing number of hospital admissions due to favorable reimbursement policies and the ability to handle emergencies augments the segment's growth. Hospitals acquire advanced technologies, necessitating skilled professionals. The need for multidisciplinary expertise in a hospital to cater to the huge patient requirements also propels the segment's growth. Additionally, hospitals provide 24/7 services. Hence, they require healthcare staff for both day and night shifts. The clinics segment is predicted to witness significant growth in the market over the forecast period. The increasing number of specialized clinics globally and the rising adoption of specialized equipment foster the segment's growth. Clinics require skilled professionals to operate such specialized equipment, providing state-of-the-art care to the patients. They also need healthcare staffing to maintain operational efficiency and accommodate fluctuating needs. Top Companies in the Market Envision Healthcare Corporation AMN Healthcare CHG Management, Inc Maxim Healthcare Group Cross Country Healthcare, Inc. Aya Healthcare Trustaff TeamHealth Adecco Group Recent Breakthroughs in the Healthcare Staffing Market In December 2024, Aya Healthcare announced the acquisition of Cross-Country Healthcare, valued at $615 million. The acquisition enables healthcare professionals to achieve their goals, ensuring clinical excellence and exceptional patient care. In September 2024, Jackson Healthcare announced the launch of Jackson HealthPros, a healthcare staffing agency, to serve the national allied health staffing market. The new company enables hiring healthcare staff in specialized areas, such as imaging, radiology, laboratory, respiratory therapy, and surgery. Browse More Insights of Towards Healthcare: Clinical Trial Design Market Size: Dental Services Organization Market Size: Neurotechnology Market Size: Companion Animal Health Market Size: U.S. Healthcare ERP Market Size: Cannabidiol Market Size: Nutraceuticals Market Size: Robotic Surgery Market Size: Digital Psychotherapeutics Market Size: Medical Affairs Outsourcing Market Size: Segments Covered in the Report By Service Type Travel Nurse Staffing Locum Tenens Staffing Per Diem Nurse Staffing Allied Healthcare Staffing By End-Use Hospitals Clinics Ambulatory Facilities Others By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
30-04-2025
- Health
- Yahoo
Dental Market Size Shows Strong Investment Potential with 11.84% CAGR by 2034
According to Towards Healthcare insight, the global dental market size is calculated at USD 44.33 billion in 2025 and is expected to reach around USD 121.36 billion by 2034, growing at a CAGR of 11.84% for the forecasted period. Ottawa, April 30, 2025 (GLOBE NEWSWIRE) -- The global dental market size was valued at USD 39.64 billion in 2024 and is predicted to hit around USD 121.36 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The rising prevalence of dental disorders and the growing awareness of oral health drive the market. North America dominated the global market due to technological advancements and favorable reimbursement policies. Get All the Details in Our Solutions – Request a Brochure: Market Overview The dental field refers to diagnosing, preventing, managing, and treating gum, teeth, and mouth disorders. Dental professionals, such as dentists and dental auxiliaries, perform these procedures. The different types of dental specialists are endodontists, oral surgeons, orthodontists, periodontists, and prosthodontists. They use modern technology and equipment, such as X-rays, lasers, drills, brushes, and scalpels. Some common tasks of dentistry include filling cavities, removing decay from teeth, repairing damaged teeth, and checking the growth of teeth and jawbones. Dental Market Trends Rising Prevalence of Dental Disorders: The rising prevalence of dental disorders encourages people to visit a dental clinic. The most common dental disorders are dental caries and periodontal disease. The World Health Organization (WHO) estimates that oral diseases affect 3.7 billion people globally. Growing Awareness for Oral Health: People, especially in underdeveloped and developing countries, are becoming more aware of oral hygiene. This is a result of several awareness campaigns by the government and private organizations, and social media. Technological Advancements: Numerous dental organizations adopt innovative dental equipment for enhanced dental care. Examples of technological advancements in dentistry include laser dentistry, digital imaging, and robotic surgery. These technologies improve patient outcomes by making dental care safer and more effective. You can place an order or ask any questions, please feel free to contact us at sales@ Limitations & Challenges in the Dental Market Lack of Skilled Professionals: Several low- and middle-income countries do not have sufficient skilled professionals to deliver advanced dental services. This limits the accessibility of dental treatment for patients from such countries. High Equipment Cost: The cost of modern dental equipment is very expensive, limiting the affordability of small- and medium-sized dental enterprises. Additionally, the cost of dental treatment using such modern equipment is also high. Hence, patients from low- and middle-income groups cannot afford. 3D Printing: Redefining the Future of Dentistry 3D printing is a technology that generates three-dimensional objects from a digital file. This technology has increasingly been adopted in dental organizations to deliver more accurate, cost-effective, and faster treatments. Stereolithography, digital light processing, and material jetting are the most common 3D printing technologies used in dentistry. These technologies are used to produce synthetic polymers, ceramics, and metals. They enhance manufacturing speed and enable customized products based on patients' requirements. This reduces cost and saves time for dental professionals and patients. As printing technology and printable materials advance, a future can be envisioned where 3D printed prosthetics and biomaterials can be customized to fit patients' needs. For instance, In March 2025, researchers from the University of Queensland, Brisbane, developed scaffolds using 3D printing technology to promote bone regeneration and subsequent dental implantation. Regional Analysis Get the latest insights on healthcare industry segmentation with our Annual Membership: Favorable Reimbursement Policies Dominated North America North America dominated the global dental market share by 40% in 2023. The rising adoption of advanced technologies and a robust healthcare infrastructure are the major growth factors of the market in North America. The countries have favorable government and private reimbursement policies, benefiting dentists and patients. Several government organizations support the development and launch of novel dental equipment. The increasing investments and collaborations among dental professionals also contribute to market growth. The growing number of dental organizations equipped with cutting-edge technologies promotes state-of-the-art treatment. United States: According to the American Dental Association, the national dental expenditures in the U.S. were $174 billion in 2023. Out of these, $69 billion was spent by private health insurance, and $68 billion was out-of-pocket. The Centers for Medicare and Medicaid Services also reimburse dental services in the U.S. Canada: The Canadian Dental Care Plan was launched by the federal government and covered 2 million senior citizens with an adjusted family income of less than $90,000. The plan aims to cover 9 million Canadians. In 2025, online applications will open for uninsured Canadians between 18 to 64 years. Rising Prevalence of Dental Disorders Promote Asia-Pacific Asia-Pacific is anticipated to grow at the fastest rate in the dental market during the forecast period. The rising prevalence of dental disorders and the increasing pediatric and geriatric population augment the market. Several government and private organizations conduct workshops and seminars to create awareness about oral hygiene among the general public. Favorable government initiatives and increasing investments foster the market. The increasing number of dental clinics and the burgeoning dental industry propel market growth. China: According to the Fourth National Oral Health Epidemiological Survey (FNOHES), Chinese adults aged 35-44 years reported 89% of dental caries. The Chinese government launched the Oral Health Action Plan (2019-2025) to provide a socially supportive environment for oral health and increase awareness by 2025. India: It is estimated that 3 in 10 people in India suffer from dental caries due to increased life expectancy and longevity of dentition. The Indian government's National Oral Health Program aims to provide integrated and comprehensive oral healthcare. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule a call today: Segmental Outlook Type Insights The dental consumables segment held a dominant presence in the dental market in 2024. Dental consumables are all materials that are required in a dental organization, such as chemicals and medicines, as well as products that assist in dental surgeries. Consumables required depend on the type of dental procedures and the operators' preference. Most of the consumables used in a dental practice are single-use, preventing the risk of contamination. They are affordable and are essential in every dental organization. The growing awareness among the general public about oral health encourages them to have regular dental check-ups. The dental equipment segment is predicted to witness significant growth in the market over the forecast period. Some common examples of specialized dental equipment include intraoral cameras, 3D imaging systems, surgical microscopes, dental lasers, and portable dental equipment. These types of equipment fulfill the needs of every dental practice and provide specialized services, like endodontics. The advent of advanced technologies, such as artificial intelligence and 3D printing, boosts the segment's growth. End-User Insights The solo practices segment held the largest share of the dental market in 2024. Solo practices can enable dental professionals to provide personalized care to patients. The dentist has complete control over all the operations of a dental organization, such as diagnosing and treating a patient, billing, and other administrative tasks. This helps to maintain the privacy of patient data. Patients can receive greater autonomy and flexibility, facilitating trust and strengthening the dentist-patient relationship. The DSO/group practices segment is anticipated to grow with the highest CAGR in the market during the studied years. Dental services organizations (DSOs) are support organizations that connect with dental practices. Numerous dental professionals prefer to collaborate to provide advanced care. Patients can benefit from multiple professionals to get multidisciplinary expertise. Several administrative and management tasks are distributed among other professionals, reducing the burden on individual dentists. There are more than 65 DSOs in the U.S., representing thousands of dental offices and serving millions of patients. Top Companies in the Market 3M Align Technology, Inc. Biolase, Inc. Bicon Dental Implants Danaher Corporation Dentsply Sirona, Inc. Envista Holdings Corporation GC Corporation Henry Schein, Inc. Implant Direct Nobel Biocare Patterson Companies Perceptive Straumann Group TBS Dental Recent Breakthroughs in the Dental Market In September 2024, the world's first fully automated dental procedure was performed by Perceptive, a U.S.-based start-up, using a robotic arm, AI, and 3D imaging. This technology enhanced the precision and efficiency of dental procedures. The dental professionals scanned the patient's mouth, analyzed the data, and used a series of tools. In September 2024, Solventum announced the launch of two innovative products, 3M Clinpro Clear Fluoride and 3M Filtek Easy Match, at the FDI World Dental Congress. These novel solutions were prepared to enhance the efficiency and patient-centered care. Browse More Insights of Towards Healthcare: Dental Tourism Market Sales: U.S. Dental Services Organization Market Sales: U.S. Dental Insurance Market Sales: Dental Insurance Market Sales: Oral Thrombopoietin Receptor Agonists Market Sales: Oral Factor Xa Inhibitors Market Sales: Direct Oral Anticoagulants (DOACs) Market Sales: Oral Care Market Sales: U.S. Behavioral Health Market Sales: AI in Behavioral Healthcare Market Sales: Segments Covered in the Report By Type Dental Consumables Dental Restoration Products Dental Implants Endosteal Implants Superperiostal Implants Transosteal Implants Dental Prosthetics Crowns Bridges Abutments Dentures Others Orthodontics Clear Aligners Conventional Braces Endodontics Others Dental Equipment Dental Radiology Equipment Dental Lasers Dental Surgical Navigation Systems CAD/CAM Equipment Dental Chairs Others By End-User Solo Practices DSO/Group Practices Others By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: in to access your portfolio
Yahoo
28-04-2025
- Business
- Yahoo
Polyclonal Antibodies Market Size is Valued at USD 2.74 Bn by 2034, Driven by a 5.04% CAGR
According to Towards Healthcare research, the global polyclonal antibodies market size is calculated at USD 1.76 billion in 2025 and is expected to reach around USD 2.74 billion by 2034, growing at a CAGR of 5.04% for the forecasted period. Ottawa, April 28, 2025 (GLOBE NEWSWIRE) -- The global polyclonal antibodies market size was valued at USD 1.68 billion in 2024 and is predicted to hit around USD 2.74 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The polyclonal antibodies market is expanding due to the rising prevalence of chronic disorders and advancements in diagnostics. North America led the global market owing to state-of-the-art R&D facilities and the presence of key players. Get All the Details in Our Solutions – Request a Brochure: Market Overview Polyclonal antibodies are a complex mixture of antibodies produced from different types of plasma B cells. Each antibody recognizes different epitopes of the same antigen. The polyclonal antibody extraction process is inexpensive and isolates large quantities of antibodies in a single extraction. These antibodies bind to an antigen and stimulate the body's immune system to destroy that antigen. They are used in lab tests to diagnose diseases, study disease progression, and treat certain disorders. Several factors govern the market growth, including the rising prevalence of chronic disorders and growing research. The increasing investments in R&D activities also boost the market. Technological advancements have led to the development of innovative extraction techniques. The burgeoning biopharmaceutical sector increases the development of novel antibody drugs. The growing use of laboratory diagnostic tests also potentiates the demand for polyclonal antibodies. Polyclonal Antibodies Market Trends Rising Prevalence of Chronic Disorders: The rising prevalence of chronic disorders potentiates the demand for polyclonal antibodies, which are used to diagnose and treat such disorders. They are also used to treat some medication overdoses, snake venoms, and blood conditions. Advancements in Diagnostics: The rising need for early disease diagnosis leads to advancements in diagnostics. Immunodiagnostics, such as ELISA and immunohistochemistry, use polyclonal antibodies to detect infectious diseases and cancer. Growing Research & Development Activities: The increasing chronic disorder cases necessitates researchers to develop novel drugs and medical devices. This requires a detailed understanding of disease progression. Research antibodies enable researchers to understand how diseases affect human bodies. You can place an order or ask any questions, please feel free to contact us at sales@ Limitations & Challenges in the Polyclonal Antibodies Market Lack of Specificity: Polyclonal antibodies are extracted from a natural source. Hence, they aren't consistent, leading to batch-to-batch variability. This leads to a lack of specificity, restricting their usage. Cross-Reactivity: Polyclonal antibodies have a high chance of cross-reactivity due to recognition of multiple epitopes. This can cause issues when using them in testing or research, leading to false positives. Virtual Immunization: A Computational Approach for Development Artificial intelligence (AI) and other in silico approaches are leveraged to revolutionize polyclonal antibody discovery and development. These techniques can be used to select, screen, and optimize antibody sequences. This enables the rational design of antibody characteristics, such as binding sites and kinetics. Such virtual modifications may help researchers to develop antibodies with enhanced efficacy. The technique may reduce the dependence on expensive trial-and-error experimental methods. Moreover, advanced computational methods can assist in mapping the polyclonal responses within individuals, guiding the selection and optimization of antibody mixtures for therapeutic or diagnostic applications. Regional Analysis Get the latest insights on healthcare industry segmentation with our Annual Membership: Presence of Key Players Dominated North America North America dominated the global polyclonal antibodies market in 2023. The rising prevalence of chronic disorders and the increasing adoption of advanced technologies drive the market. The availability of state-of-the-art research and development facilities leads to the development of novel antibody-based drugs. The presence of key players, such as Thermo Fisher Scientific, Pfizer, and Rapid Novor, holds the major share of the market in North America. Favorable government policies and regulatory frameworks enable pharma and biotech companies to launch novel products. United States: The Food and Drug Administration (FDA) regulates the approval of antibody-based drugs in the U.S. In 2023, 12 antibody-based drugs were approved. Canada: In September 2024, UBC researchers at Canada's Immuno-Engineering & Biomanufacturing Hub (CIEBH) received funding of more than $31.4 million for three projects for the development of immune-based therapeutics, like mRNA vaccines, antibody treatments, and cell & gene therapies, in British Columbia for Canadians. Asia-Pacific is anticipated to grow at the fastest rate in the polyclonal antibodies market during the forecast period. The increasing geriatric population leads to rising chronic disorders. The growing research and development activities and demand for innovative therapeutics augment the market. The increasing number of pharma and biotech startups and the rapidly expanding biopharmaceutical sector boost the market. Favorable government support, as well as increasing investments and collaborations, also contribute to market growth. China: China has emerged as a major supplier of polyclonal antibodies globally. There are around 112 polyclonal antibody suppliers in China. Wuhan Elabscience Biotechnology Co., Ltd., Fapon International Ltd., and Wuhan ServiceBio Technology Co., Ltd. account for 77% of the total supply of polyclonal antibodies in China. India: In 2025, 481 polyclonal antibody tenders were published in India. The Indian government's 'Make in India' initiative encourages local researchers and developers to extract and manufacture polyclonal antibodies in India Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule a call today: Segmental Outlook Product Insights The secondary antibodies segment held a dominant presence in the polyclonal antibodies market in 2024. Secondary antibodies bind to the primary antibody, which in turn binds to antigens. They are widely used for the detection, sorting, or purification of target antigens. The demand for secondary antibodies is high, as they are easy to manufacture and cost-effective. Manufacturers can supply ready-to-use secondary antibodies that are appropriate for all applications. The increasing use of ELISA and Western blotting promotes the need for secondary antibodies as they are chemiluminescent, colorimetric, or fluorescence-based, boosting the segment's growth. The primary antibodies segment is expected to grow at the fastest rate in the market during the forecast period. Primary antibodies are essential components as they directly bind to the antigens. They are highly specific and sensitive to detect even minute changes in antigens. They are widely used for detecting and analyzing the presence of biomarkers in several disorders, such as Alzheimer's disease, diabetes, cancer, and Parkinson's disease, both quantitatively and qualitatively. Application Insights The diagnostics segment held the largest share of the polyclonal antibodies market in 2024. Polyclonal antibodies are vital for diagnosing disease conditions. Favorable government policies for early disease detection augment the segment's growth. Early detection enables healthcare professionals to make effective clinical decisions. The growing demand for personalized therapeutics also potentiates the need for molecular diagnostics. Technological advancements lead to innovations in immunoassay techniques, such as ELISA, Western blot, immunohistochemistry, and flow cytometry. The biomedical research segment is predicted to witness significant growth in the market over the forecast period. Biomedical research refers to investigating biological processes and cellular and molecular mechanisms of human diseases using scientific methods. Polyclonal antibodies play a vital role in assessing the disease progression, allowing researchers to develop targeted therapeutics. The growing proteomics and genomics research also fosters the segment's growth. Source Insights The rabbit segment led the global market in 2024. Polyclonal antibodies extracted from rabbits usually possess a strong and diverse immune response. Rabbits are increasingly preferred as host species for a variety of applications, such as research, diagnostics, and clinical applications. Polyclonal antibodies from rabbits result in the extraction of high-affinity antibodies. Hence, they provide more extensive target recognition capabilities compared to other antibodies. The mouse segment is anticipated to grow with the highest CAGR in the polyclonal antibodies market during the studied years. The increasing demand for a mouse as a preferred laboratory animal propels the segment's growth. The extraction process of polyclonal antibodies from a mouse is generally easier than from rabbits. Mice have a strong immune system and are capable of generating a robust antibody response. Additionally, mice have greater genetic similarities to humans, eliminating the need for major modifications. End-Use Insights The hospitals & diagnostic centers segment registered its dominance over the global market in 2024. Polyclonal antibodies have widespread clinical applications, including disease diagnosis and treatment. The rising prevalence of infectious diseases and cancer necessitates that patients visit diagnostic laboratories, increasing the demand for immunodiagnostics. The growing number of antibody-based drug launches contributes to the segment's growth. Hospitals & diagnostic centers have favorable infrastructure and suitable capital investments to adopt advanced diagnostics and therapeutics. The pharmaceutical & biotechnology companies segment is projected to expand rapidly in the polyclonal antibodies market in the coming years. The segmental growth is attributed to the growing research and development activities, the presence of skilled professionals, and favorable infrastructure. The rising number of biopharma startups increases market competitiveness. This encourages companies to expand their product pipeline, potentiating the development of antibody-based drugs. Top Companies in the Market Thermo Fisher Scientific Inc. Merck KGaA Abcam plc. ProteoGeni Proteintech Group, Inc. Bio-Rad Laboratories Inc. BPS Bioscience, Inc. R&D Systems, Inc. Agilent Technologies, Inc. Atlas Antibodies Cusabio Technology LLC Rockland Immunochemicals, Inc. Recent Breakthroughs in the Polyclonal Antibodies Market In October 2024, the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) provided a grant to GigaGen, Inc. of $135.6 million over six years. The investment was provided to develop recombinant polyclonal antibody therapeutics targeting botulinum neurotoxins (BoNT). In August 2024, the U.S. FDA approved the Phase 1 clinical trial of GIGA-2339, a recombinant polyclonal antibody treatment for hepatitis B virus (HBV) infection, developed by GigaGen. The trial will test the safety and tolerability of GIGA-2339. Browse More Insights of Towards Healthcare: Anti-Inflammatory Drugs Market Regulatory Trends and Strategies by 2034 Anti-Obesity Drugs Market Size, Trends, Innovations and Growth Drivers Monoclonal Antibodies in Veterinary Health Market Advancing Animal Health and Disease Management Monoclonal Antibodies Therapeutics Market Drivers & Future Trends Sterile Antimicrobial Gel Market Size to Extend $3.05 Bn by 2034 Direct Oral Anticoagulants (DOACs) Market to Boost $102.36 Bn by 2034 Complement C4 Antibody Market Size to Hit $68.48 Bn by 2034 Anti-Viral Nasal Spray Market Size and Developments Antisense and RNAi Therapeutics Market to Soar USD 30.03 Bn by 2033 Antibody Drug Conjugate Market Size (USD 27.37 Bn) Report by 2033 Segments Covered in the Report By Product Secondary Antibodies Primary Antibodies By Application Diagnostics Biomedical Research By Source Rabbit Mouse Goat Sheep Others By End-Use Hospitals & Diagnostic Centers Pharmaceutical & Biotechnology Companies Academic & Research Center By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Access Our Premium Strategic Solution @ You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: in to access your portfolio
Yahoo
24-04-2025
- Health
- Yahoo
AI in Mental Health Market Size Set to Grow USD 11.84 Billion by 2034 at 24.15% CAGR
According to Towards Healthcare, the global AI in mental health market size is calculated at USD 1.80 billion in 2025 and is expected to reach around USD 11.84 billion by 2034, growing at a CAGR of 24.15% for the forecasted period. Ottawa, April 24, 2025 (GLOBE NEWSWIRE) -- The global AI in mental health market size was valued at USD 1.45 billion in 2024 and is predicted to hit around USD 11.84 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The rising prevalence of mental disorders and technological advancements are the major growth factors of the market. North America dominated the global market due to the increasing use of AI in healthcare and the growing demand for personalized medicines. Get All the Details in Our Solutions – Request a Brochure: AI in Mental Health Market Overview Artificial intelligence (AI) has revolutionized the detection and treatment of mental health disorders. It offers advanced detection approaches, tailored therapies, and virtual therapeutic platforms, leading to increased healthcare access and better treatment outcomes. Numerous AI algorithms, such as machine learning, computer vision, natural language processing, and generative AI, play a vital role in performing different functions to transform mental healthcare. These algorithms offer enhanced accuracy and precision, reducing manual errors. The rising prevalence of mental health disorders necessitates their early diagnosis and treatment. The growing demand for personalized medicines favors the development of cognitive behavioral therapy, depending on the patient's conditions. The growing awareness about mental health as a significant health concern encourages the general public to treat it. Numerous government organizations launch initiatives for the screening and early detection of mental disorders. AI in Mental Health Market Trends Rising Prevalence of Mental Health Disorders: The rising prevalence of mental health disorders globally is a major public health concern. The different types of mental disorders include anxiety, depression, bipolar disorder, and schizophrenia. Depression is the most common disorder, affecting around 280 million people globally. Technological Advancements: Ongoing efforts are made to develop advanced and innovative tools for screening and early detection of mental health disorders. Researchers are also developing algorithms that can analyze speech patterns to detect anxiety and predict psychiatric episodes before they occur. Increasing Investments: Several government and private organizations provide funding to support the adoption of AI tools and algorithms for mental health disorders. The increasing venture capital investments for healthcare startups also contribute to the market. You can place an order or ask any questions, please feel free to contact us at sales@ Limitations & Challenges in the AI in Mental Health Market Biasedness: AI algorithms can provide biased results due to inaccuracies and imbalances in datasets while training algorithms. This leads to incorrect results and potentially affects clinical decisions, thereby reducing treatment outcomes. Privacy & Data Protection: Another major challenge is the privacy & data protection when using AI algorithms to detect a patient's mental health condition. There are high chances of security breaches, leading to the leakage of sensitive patient information. Regulatory Hurdles: There are currently no clear and comprehensive regulatory frameworks governing the use of AI in mental health. This limits the development of novel AI-enabled medical devices, restricting market growth. Wearable Devices: Transforming Mental Health The rising adoption of wearable devices can prove to be beneficial in identifying a patient's mental health status. AI-enabled wearable devices can monitor a patient's sleep patterns, physical activity, and variations in heart rate and rhythm. This gives an idea to assess the user's mood and cognitive state. These devices can be used by individuals for the prescreening assessment of mental health disorders, like anxiety and depression. Through wearable devices, healthcare professionals can continuously monitor a patient's condition. AI-based wearable devices create ample opportunities for patients and healthcare professionals in the future, facilitating remote monitoring. This benefits the geriatric population, as they are more prone to mental health disorders, affecting 14% of adults over 60 years globally. Get the latest insights on healthcare industry segmentation with our Annual Membership: Regional Analysis Technological Advancements Dominated North America North America dominated the global AI in mental health market in 2024. The rising prevalence of mental health disorders and the increasing adoption of advanced technologies in healthcare drive the market. The presence of key players develops advanced AI tools for the diagnosis and treatment of mental disorders. The growing demand for personalized medicines also promotes market growth. Advanced healthcare infrastructure and growing research and development activities also contribute to the market. United States: The National Institute of Health (NIH) estimated that more than 57 million Americans are affected by mental illness. The Trump Administration issued a new executive order in 2025 to remove barriers to innovation and position the U.S. as a global leader in AI. Canada: According to a Canadian Mental Health Association report, 57% of adults aged 18-24 years had early signs of mental illness. E-Mental Health Strategy for Canada highlights the need for safety concerning the application of AI in mental healthcare for Canadians. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule a call today: Growing Awareness Promotes Asia-Pacific Asia-Pacific is projected to host the fastest-growing AI in mental health market in the coming years. The government and private institutions conduct workshops and seminars to create awareness among the general public about mental health. This increases the demand for the development of innovative AI-enabled medical devices and mobile apps, improving healthcare outcomes for people living in Asia-Pacific countries. Favorable government initiatives and growing investments boost the market. The rising collaborations and the burgeoning healthcare sector also govern market growth. China: Autism is the leading mental health disability among children in China, affecting around 2 million children from 0-14 years. Recently, the researchers at Feng's Innovation Center developed an AI system for early diagnosis and identification of Autism Spectrum Disorder, resulting in a diagnostic accuracy rate of 91.67%. India: The Indian government's tele-mental health program, Tele MANAS, facilitates 24x7 remote access to mental health. The Tele MANAS app was launched in 2024 with self-care resources, stress management tools, and direct consultation services. Segmental Outlook Offering Insights The software segment held a dominant presence in the AI in mental health market in 2024 and is expected to grow at the fastest CAGR during the forecast period. AI-enabled software increases access to advanced mental health services due to the increasing use of smartphones. People can monitor their mental health status and send real-time data to their doctors. Additionally, AI-powered chatbots and virtual therapists assist patients with psychological disorders in identifying their problems. Integrating AI-enabled software in healthcare settings eliminates the need for favorable infrastructure for its installation. Technology Insights The natural language processing (NLP) segment led the global market in 2024. NLP can support the analysis and management of large datasets and can classify datasets based on a patient's condition. It can facilitate information extraction, sentiment analysis, and emotion detection. It is predominantly used for simulating human conversations as well as creating and understanding clinical documentation. NLP can facilitate the early diagnosis of mental health disorders by analyzing human language. The machine learning (ML) segment is anticipated to grow with the highest CAGR in the AI in mental health market during the studied years. ML and deep learning (DL) algorithms enhance the diagnostic accuracy of mental health conditions. They can analyze vast amounts of patient data, such as electronic health records and brain scans, to detect abnormalities that are not visible to a human. It can identify patterns and predict the possibility of mental health disorders in the near future. ML and DL algorithms have been found to enhance the diagnostic accuracy. Disorder Insights The anxiety segment held the largest share of the market in 2024. Anxiety is the most common mental disorder globally. The rising prevalence of anxiety disorders augments the segment's growth. According to the WHO, 4% of the global population experiences anxiety disorder. The major risk factors of anxiety include trauma, stress, genetics, and substance abuse. Anxiety disorder can significantly impact a person's lifestyle, reduce productivity at the workplace, and also lead to social isolation. Hence, early detection of anxiety disorders is necessary. Only 1 in 4 people (27.6%) in need receive any treatment for anxiety disorders. The schizophrenia segment is predicted to witness significant growth in the AI in mental health market over the forecast period. Schizophrenia is a complex, multi-dimensional disorder with varying degrees of psychotic, negative, cognitive, and motor manifestations. It is caused by a variety of factors, including genetic, biological effects, and environmental factors. Schizophrenia is estimated to affect more than 24 million people globally, accounting for 1.5 per 10,000 people. AI can be used to detect and develop novel, tailored antipsychotic drugs for the effective treatment of Schizophrenia patients. Top Companies in the Market Spring Care, Inc. Wysa Ltd, Lyra Health, Inc. Woebot Health Quartet Meru Syra Health New Life Solution, Inc. (meQ) Aiberry Limbic Ellipsis Health Kintsugi Mindful Wellness, Inc NextGen Healthcare SilverCloud (American Well Corporation) Fortis Healthcare HEADSPACE HEALTH Microsoft Google Recent Breakthroughs in AI in Mental Health Market In April 2025, Lyra Health announced the launch of its new AI platform, Lyra Connect, in the next 12 months. The platform compares workplace information against peers, industries, and evidence-based best practices, along with predictive analytics to help HR leaders plan. The real-time data enables HR to respond quickly to workplace issues. In April 2025, researchers from Dartmouth College's Geisel School of Medicine developed Therabot, a gen AI-powered therapy chatbot to enable users to interact with a digital presence. The mobile app demonstrated greater symptom reductions in patients with major depressive disorder (MDD), generalized anxiety disorder (GAD), and feeding and eating disorders in more than 200 participants of a randomized controlled trial. Browse More Insights of Towards Healthcare: Laboratory Information Management Systems Market Size: Patient Centric Healthcare App Market Size: Natural Language Processing (NLP) in Healthcare and Life Sciences Market Size: Nurse Call Systems Market Size: Medical Terminology Software Market Size: Generative AI in Healthcare Market Size: Software as a Service for Behavioral Health Market Size: Healthcare ERP Market Size: Healthcare Automation Market Size: Healthcare Digital Twin Market Size: Segments Covered in the Report By Offering Software Services By Technology Natural Language Processing Text Analytics Speech Analytics Smart Assistance Others Machine Learning Deep Learning Others By Disorder Anxiety Depression Schizophrenia Post-traumatic Stress Disorder (PTSD) Insomnia Others By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us:
